Fidji Simo Steps Back from OpenAI: Illness, Decision, and Next Chapter
Fidji Simo announced on July 9, 2026, that she is stepping down from her full-time role at OpenAI to become a part-time advisor. The decision follows a three-month medical leave that began in April 2026 due to an acute worsening of her chronic condition. In a public statement, she explained that her recovery had taken longer and been more complex than initially expected.
Her departure comes shortly after OpenAI confidentially filed for an initial public offering, a process that remains ongoing with no confirmed timeline. Simo previously served as the CEO of Instacart, where she led the company through its own public listing.
In her statement, Simo reflected on the past seven years, noting that she had spent “countless hours” in doctors’ offices managing symptoms, treatments, insurance, and uncertainty. She revealed that she had been offered a one-year medical leave at Facebook back in 2019, shortly after her diagnosis, but declined the offer. She recalled that Mark Zuckerberg had advised her to “think long-term,” a piece of guidance she now regrets not following.
During her tenure at OpenAI, Simo was responsible for the company’s applications business and was involved in preparations for the IPO filing. According to reports from Bloomberg and The New York Times, the timeline for the public offering remains uncertain, with some suggesting it may be delayed. For more context on OpenAI’s valuation and market positioning, see GigaNectar’s analysis on AI infrastructure.
Even as she steps back from day-to-day management, Simo will continue to support OpenAI as an advisor. She will also remain active in healthcare AI through her co-founded ventures, Chronicle BioAI and CODA Research, which focus on applying artificial intelligence to medical challenges.
Fidji Simo’s departure was announced on July 9, 2026, via a public statement. The announcement detailed her transition to a part-time advisory role at OpenAI and included reflections on her seven-year journey with POTS. OpenAI CEO Sam Altman responded with gratitude for her work. The leadership change follows the company’s confidential IPO filing, the timing of which has not been finalized. Simo will maintain an advisory connection to OpenAI while continuing her work in AI-driven healthcare initiatives.
🔗 Further reading on GigaNectar: Apple chip shortage · OpenAI GPT-5/6 rollout · NVIDIA revenue model · Illinois AI Safety Act
